Retail & Wholesale » Retail | China Pioneer Pharma Holdings Ltd.

China Pioneer Pharma Holdings Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,605
1,939
1,802
2,092
2,484
1,924
Cost of Goods Sold (COGS) incl. D&A
1,118
1,324
1,244
1,406
1,648
1,175
Gross Income
487
615
558
686
836
749
SG&A Expense
170
262
252
419
503
579
EBIT
317
353
306
267
336
170
Unusual Expense
11
5
60
46
1
48
Non Operating Income/Expense
20
5
20
14
8
1
Interest Expense
16
18
25
6
3
2
Pretax Income
353
403
291
376
371
144
Income Tax
46
55
42
51
33
26
Equity in Affiliates
9
19
36
46
15
17
Consolidated Net Income
297
328
213
279
324
100
Net Income
301
329
215
277
322
100
Net Income After Extraordinaries
301
329
215
277
322
100
Net Income Available to Common
301
329
215
277
322
100
EPS (Basic)
0.29
0.25
0.16
0.21
0.25
0.08
Basic Shares Outstanding
1,047
1,333
1,313
1,295
1,290
1,250
EPS (Diluted)
0.29
0.25
0.16
0.21
0.25
0.08
Diluted Shares Outstanding
1,047
1,333
1,313
1,295
1,290
1,250
EBITDA
320
362
327
283
345
180
Other Operating Expense
-
-
-
-
3
-
Non-Operating Interest Income
15
47
51
22
21
19
Minority Interest Expense
3
1
2
1
2
-

About China Pioneer Pharma Holdings

View Profile
Address
No.15, Lane 88 Wuwei Road
Shanghai Shanghai 200331
China
Employees -
Website http://www.pioneer-pharma.com
Updated 07/08/2019
China Pioneer Pharma Holdings Ltd. is an investment company, which engages in the manufacture, promotion, and sale of pharmaceutical products. It operates through the Ophthalmic Pharmaceutical Products and Group's Pharmaceutical Products and Medical Devices Except for Ophthalmic Pharmaceutical Products segments. The Ophthalmic Pharmaceutical Products segment involves in the sales of the Group's ophthalmic pharmaceutical products to the customers under the co-promotion and channel management arrangement.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.